
The pharmaceutical market is experiencing steady growth, driven by increasing demand for innovative treatments amid an aging population and rising prevalence of rare and chronic diseases. Continued research and development (R&D) innovation resulting in the discovery and development of new drugs and treatment options would boost the industry’s prospects.
Considering these factors, investors could consider buying top pharmaceutical stocks Pacira BioSciences, Inc. (PCRX), Calliditas Therapeutics AB (publ) (CALT), and Astellas Pharma Inc. (ALPMY) poised for significant growth.